Intra-Cellular Therapies Inc.

Q4 2024 13F Holders

Symbol
ITCI
CUSIP
46116X101
Type
Equity
Class
COM
Num filings
408
Total reported value, excl. options
$8.08 B
Manager Report Date Value ($000) Shares Option Type